UK serum and blood sample shortage threatens IVD (in vitro diagnostic) industry
This article was originally published in Clinica
Executive Summary
UK IVD manufacturers who require serum and blood samples for developing assays and for batch release testing are finding the UK an increasingly difficult market in which to operate. Most UK hospital trusts have stopped giving away for free, as they used to, excess serum and plasma samples. The main reason is the fear of criticism by the press and the increasingly litigious medical environment.
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.